Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (NASDAQ: SKIN) generates a steady flow of news at the intersection of medical technology, professional aesthetics, and beauty. As the parent of Hydrafacial, SkinStylus, and Keravive, the company issues regular updates on financial performance, science-backed innovation, provider partnerships, and corporate governance, giving investors and industry followers insight into how its skin health platform is evolving.
On this page, readers can follow earnings announcements and financial results, where BeautyHealth reports net sales, gross margin, adjusted EBITDA, delivery systems sold, and active install base across the Americas, Asia-Pacific, and EMEA. These releases often include management commentary on trends in device sales versus consumables, the performance of the recurring revenue stream, and changes in regional go-to-market strategies.
News coverage also highlights product and innovation updates, such as the launch of boosters like HydraFillic with Pep9 and references to Hydralock HA Booster, as well as insights from the company’s Skintuition Report, which explores consumer trends in modern skin health and aesthetics. Additional stories focus on initiatives like the Hydrafacial Advisory Councils and Ambassador Network, which bring together plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide product development, education, and clinical research.
Corporate and governance news includes executive appointments, board changes, and capital structure developments, such as the appointment of a new President and Chief Executive Officer, the addition of a new independent director, and updates related to convertible senior notes and charter amendments. For anyone tracking SKIN, this news feed offers a centralized view of the company’s operational progress, strategic priorities, and role in professional skin and scalp health.
The Beauty Health Company (NASDAQ:SKIN) announced that Brent Saunders, Executive Chairman, and Liyuan Woo, CFO, will present at Piper Sandler’s 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 a.m. ET. A webcast of the presentation will be available on the Company’s investor relations website, with an archived replay accessible afterward.
BeautyHealth focuses on innovative beauty products, with its flagship HydraFacial offering a non-invasive skin care solution available in over 87 countries.
The Beauty Health Company (NASDAQ: SKIN) announced the departure of CEO Clint Carnell, effective December 31, 2021, coinciding with a record third quarter performance. Brent Saunders, Executive Chairman, will serve as interim CEO until a permanent replacement is found. The transition is not related to financial concerns, and the company is focused on growth through brand awareness, innovation, and international expansion. Carnell expressed pride in his five-year tenure, during which he navigated the business through significant challenges.
The Beauty Health Company (NASDAQ:SKIN) reported impressive third-quarter results for 2021, with net sales of $68.1 million, a 97% increase from Q3 2020. The company raised its full-year revenue guidance to $245-$255 million, citing strong performance across the Americas and EMEA regions despite challenges from the Delta variant. Adjusted EBITDA stood at $5.8 million. However, net loss ballooned to $215.1 million due to non-cash liabilities. Overall, BeautyHealth remains optimistic about future growth potential amid ongoing market uncertainties.
The Beauty Health Company (NASDAQ:SKIN) has completed the redemption of all outstanding public warrants from its initial public offering. As of the Redemption Date, November 3, 2021, approximately 99.5% of the public warrants were exercised. This resulted in total cash proceeds of $185.4 million, with 16,123,235 warrants exercised for cash and 74,104 on a cashless basis. The public warrants were subsequently delisted from the Nasdaq. The company's common stock continues to trade under the ticker symbol 'SKIN'.
The Beauty Health Company (NASDAQ:SKIN) will announce its third quarter 2021 financial results after the market closes on November 9, 2021. A conference call is scheduled for 4:30 p.m. Eastern Time on the same day to discuss these results. Interested participants can join the call by dialing (877) 407-9208 for domestic calls or 1 (201) 493-6784 for international calls, using conference ID 13723615. A live audio webcast will also be available for access.
The Beauty Health Company (NASDAQ:SKIN) announced a redemption of all outstanding Public Warrants for its Class A common stock at a price of $0.10 per warrant, effective November 3, 2021. This decision follows the conditions of the Warrant Agreement, which allows redemption if the stock trades above $10.00 for 20 of the 30 days prior to notice. Holders can exercise warrants until 5:00 p.m. New York City time on the Redemption Date. Unexercised warrants will be void after the Redemption Date. The Company has made no recommendations regarding the exercise of these warrants.
HydraFacial (NASDAQ:SKIN) has partnered with Epicutis to introduce the Neck & Décolleté Booster, a professional skincare product aimed at revitalizing the neckline. Combining advanced medical technology with spa therapies, HydraFacial offers personalized skin solutions using patented Vortex-Fusion® technology. The new booster is clinically proven to reduce fine lines and enhance hydration. CEO Clint Carnell stated this collaboration expands their treatment offerings, enhancing customer experience with scientifically backed ingredients.
The Beauty Health Company (NASDAQ:SKIN) announced the participation of CEO Clint Carnell and CFO Liyuan Woo in several upcoming virtual investor conferences. These include the Cowen 2nd Annual Health, Wellness & Beauty Summit on September 13, 2021, Raymond James Virtual Consumer Conference on September 14, 2021, and the Jefferies Fitness & Wellness Summit on September 15, 2021. The presentations will be available on the Company’s investor relations website and archived for later viewing.
The Beauty Health Company (NASDAQ:SKIN) announced the pricing of $650 million in 1.25% convertible senior notes due 2026. This offering increased from a previously announced $400 million. The notes are set to settle on September 14, 2021, and will accrue interest semi-annually. The initial conversion rate is set at 31.4859 shares per $1,000 principal amount, representing a conversion price of approximately $31.76 per share, a 32.5% premium over the last reported price on September 9, 2021. Net proceeds are estimated at $631.5 million, intended for future acquisitions and working capital.
The Beauty Health Company (NASDAQ:SKIN) announced a proposed private offering of $400 million in convertible senior notes due 2026, potentially raising up to $60 million more. The notes, which will mature on October 1, 2026, are unsecured and will bear interest payable semi-annually. Proceeds will support capped call transactions, future acquisitions, working capital, and general corporate purposes. The offering targets qualified institutional buyers and is subject to market conditions. Forward-looking statements caution about risks affecting completion and terms of the offering.